P. Salmi

发表

Adenosine-dopamine interactions revealed in knockout mice

K. Chergui, B. Fredholm, P. Salmi, 2007, Journal of Molecular Neuroscience.

A new computer-assisted two-way avoidance conditioning equipment for rats: behavioral and pharmacological validation.

P. Salmi, S. Ahlénius, J. Samuelsson, 1994, Journal of pharmacological and toxicological methods.

The effects of methylmercury on motor activity are sex- and age-dependent, and modulated by genetic deletion of adenosine receptors and caffeine administration.

B. Fredholm, Jiang-Fan Chen, M. Vahter, 2007, Toxicology.

Endocrine and behavioral traits in low-avoidance Sprague-Dawley rats.

C. Johansson, K. Uvnäs‐Moberg, P. Salmi, 1999, Regulatory peptides.

Sedative effects of the dopamine D1 receptor agonist A 68930 on rat open‐field behavior

P. Salmi, S. Ahlénius, 2000, Neuroreport.

Endocrine and behavioral traits in low-avoidance performing Sprague–Dawley rats

M. Åstrand, C. Johansson, K. Uvnäs‐Moberg, 1999, Regulatory Peptides.

Conditioned nausea after cancer chemotherapy and autonomic nervous system conditionability.

M. Fredrikson, G. Steineck, C. Fürst, 1993, Scandinavian journal of psychology.

Dihydrexidine produces hypothermia in rats via activation of dopamine D1 receptors

P. Salmi, S. Ahlénius, 1997, Neuroscience Letters.

Evidence for functional interactions between 5-HT1A and 5-HT2A receptors in rat thermoregulatory mechanisms.

P. Salmi, S. Ahlénius, S Ahlenius, 1998, Pharmacology & toxicology.

Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.

T. Hökfelt, C. Wahlestedt, J. Skouv, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties

C. Wahlestedt, M. Heilig, P. Salmi, 2003, Regulatory Peptides.

Lack of efficacy of 'naked' small interfering RNA applied directly to rat brain.

C. Wahlestedt, B. Kull, P. Salmi, 2003, Acta physiologica Scandinavica.

Dihydrexidine--the first full dopamine D1 receptor agonist.

B. Kull, P. Salmi, R. Isacson, 2006, CNS drug reviews.

Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat.

P. Salmi, S. Ahlénius, 1994, European journal of pharmacology.

Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat.

P. Salmi, T. Karlsson, S. Ahlénius, 1994 .

A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine d1/5 receptors in the prefrontal cortex?

C. Wahlestedt, B. Kull, P. Salmi, 2004, Neuroscience.

Further evidence for clozapine as a dopamine D1 receptor agonist.

P. Salmi, S. Ahlénius, 1996, European journal of pharmacology.

The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram

P. Grillner, T. Svensson, U. Hacksell, 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

Biphasic effects of 8-OH-DPAT on endurance of treadmill performance in the male rat 1 Presented at the VIIIth ECNP Congress, Venice, Italy, Sept 30–Oct 4 1995 (Ahlenius and Salmi, 1995b). 1

P. Salmi, S. Ahlénius, P. Kaur, 1997, European Neuropsychopharmacology.

Perinatal Caffeine, Acting on Maternal Adenosine A1 Receptors, Causes Long-Lasting Behavioral Changes in Mouse Offspring

B. Fredholm, P. Salmi, Olga Björklund, 2008, PloS one.

Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion

P. Salmi, A. Mathé, S. Ahlénius, 2000, Behavioural Brain Research.

Effects of 5-HT1A receptor agonists on patterns of rat motor activity in relation to effects on forebrain monoamine synthesis.

V. Hillegaart, P. Salmi, S. Ahlénius, 1993, Pharmacology & toxicology.

Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat

T. Svensson, P. Salmi, S. Ahlénius, 1996, European Neuropsychopharmacology.

Stimulation of forward locomotion by SCH-23390 and raclopride in d-amphetamine-treated rats

K. Malmgren, T. Svensson, P. Salmi, 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

Sedative effects of the dopamine D1 receptor agonist A 68930 on rat open‐field behavior

P. Salmi, S. Ahlénius, 2000 .

Independent roles of dopamine D1 and D2/3 receptors in rat thermoregulation

P. Salmi, 1998, Brain Research.

Anti-cataleptic effects of clozapine, but not olanzapine and quetiapine, on SCH 23390- or raclopride-induced catalepsy in rats

C. Wahlestedt, P. Salmi, J. Ahlqvist, 2003, European Neuropsychopharmacology.

Dopamine D(2) receptor ribozyme inhibits quinpirole-induced stereotypy in rats.

C. Wahlestedt, B. Sproat, P. Salmi, 2000, European journal of pharmacology.

In vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptors 1 Presented in part at the `9th ECNP Congress', Amsterdam, September 21–25, 1996 (Ahlenius et al., 1996). 1

P. Salmi, S. Ahlénius, O. Magnusson, 1999, European Neuropsychopharmacology.

Sedative effects of the dopamine D1 receptor agonist A 68930 on rat open‐field behavior

P. Salmi, S. Ahlénius, 2000, Neuroreport.

In vivo effects of remoxipride and aromatic ring metabolites in the rat.

V. Hillegaart, L. Nilsson, P. Salmi, 1997, The Journal of pharmacology and experimental therapeutics.